Real-world experience versus clinical trials: pros and cons in psoriasis therapy evaluation

被引:17
作者
Cinelli, Eleonora [1 ]
Fabbrocini, Gabriella [1 ]
Megna, Matteo [1 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy
关键词
D O I
10.1111/ijd.15644
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E107 / E108
页数:2
相关论文
共 4 条
  • [1] Supplement: Ageing Research in Chinese Societies Preface
    Chen, Liang-Kung
    [J]. AGEING RESEARCH REVIEWS, 2010, 9 : S1 - S1
  • [2] Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development
    Kirsten, N.
    Livideanu, C. Bulai
    Richard, M. A.
    Konstantinou, M. P.
    Khemis, A.
    Balluteaud, C.
    Goujon, C.
    Beylot-Barry, M.
    Paul, C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (03) : 636 - 638
  • [3] Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules"
    Megna, Matteo
    Balato, Anna
    Napolitano, Maddalena
    Gallo, Lucia
    Caso, Francesco
    Costa, Luisa
    Balato, Nicola
    Scarpa, Raffaele
    [J]. CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1739 - 1741
  • [4] Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16 545 biologic-naive patients from the French National Health Insurance database (SNIIRAM)
    Sbidian, E.
    Mezzarobba, M.
    Weill, A.
    Coste, J.
    Rudant, J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 86 - 93